pwc pharma 2020: marketing the future

“Pharma 2020: Marketing the future” is the third in this series of papers on the future of the pharmaceutical industry published by PricewaterhouseCoopers. 178 23 It discusses the key forces reshaping the pharmaceutical marketplace, including the growing power of healthcare payers, Finding the right tools can make you successful. Connect with hundreds of like-minded peers to discuss the latest innovations in digital pharma marketing. Excerpted from “Pharma 2020: Marketing the Future,” the third in a series of papers on the future of the pharmaceutical industry published by PricewaterhouseCoopers. Naturally, the pharma marketer has an important ongoing role to play. Subscribe for weekly pharma marketing insights. The paper highlights some very strong facts related to the need for Pharma to change its marketing and sales functions in order to sustain future growth and performance. ]Â#A6<3ˬè¿nY-… 5 «%lÜ‚–n›áğ¨d;PP±dß“W¡j In its report, “India Pharma 2020”, McKinsey & Company had projected for $55 billion, with the potential to achieve $70 billion. The 3 rd Annual Future Pharma Marketing Summit is the only event of its kind in Canada, designed to help you overcome the unique challenges in pharmaceutical marketing. ñÀÂaP´¼{�AÀÉÅ©}Í"œLêç˜Ø4�p4)aµŞy<2�Â[¸XN.NofwéUdR¿Ğ¤S²Â Ñ¡�/åâæÓ7TcfZMuá´ÛÚu4‹‘™C„#ᙯ´M¯’‹ÿB–ˆ—‰L�F7¼e¤PĞù-d˜A1Ğè”+�ÂoŠY…H8,pfO˜Z9Ùí¼@ÔѤÍ-şpÛ_ŞŞ3ogĞonC­�i’óɤ£™½æï&v�ùNg m0ëUR>æÌŞwJÄ⢸zĞJÃO,!®Î¬3”�{=ÆÒ tÄ‹�%� The Indian pharma industry is showing signs of healthy growth and is likely to be in the top 10 global markets by value by 2020. We’re using the power of Intelligent Digital to see beyond the technology gender gap, to a world where women play an equal part in creating our future. - Based upon expected GDP growth, the pharma sector will likely triple in size by 2060 19 4. Pharma 2020. by Ben Adams A new PwC report sees M&A for biotech to be in the middling $2 billion to $10 billion range. Pharma 2020: Marketing the future - Which path will you take? Pharma 2020: Taxing times ahead Which path will you take? ISBN: 978-0-87420-442-1 Editorial Leadership Team ii Emerging Trends in Real Estate® Asia Pacific 2020 Communications, Asia Pacific London, +44 20 7804 3744, jo.pisani@uk.pwc.com • Jo has overall responsibility for PwC Strategy’s pharmaceuticals teams and focuses on business strategy, valuations, portfolio management and commercial due diligence Simon Friend – Partner, Global Head of Health Industries, London, +44 20 7213 4875, simon.friend@uk.pwc.com Meanwhile, the amount of seniors (65+ years old) in the U.S. will double to 100 million by 2060. “Pharma 2020: Challenging business models” is the fourth paper in the Pharma 2020 series on the future of the pharmaceutical industry to be Discover PwC’s four cutting-edge digital tax and regulatory solutions for pharma & life sciences companies and how they can add value to your business, help you comply with new laws and stay up to date with upcoming changes. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Start adding content to your list by clicking on the star icon included in each card. © 2017 - Sat Jan 16 07:36:02 UTC 2021 PwC. the third in the Pharma 2020 series, outlines a confluence of dynamics that lead to a new marketing and sales system with a smaller, more agile and smarter sales force. Pharma 2020: Marketing the future – Which path will you take? Set preferences for tailored content suggestions across the site, Healthcare policy makers and payers are increasingly mandating what doctors can prescribe, The boundaries between different forms of healthcare are blurring, The markets of the developing world, where demand for medicines is likely to grow most rapidly over the next 13 years, are highly varied, Governments are beginning to focus on prevention rather than treatment, Recognise the interdependence of the payer, provider and pharmaceutical value chains, Invest in developing medicines the market wants to buy, Adopt a more flexible approach to pricing, Develop plans for marketing and selling specialist therapies, Manage multi-country launches and live licensing, Form a web of alliances to offer supporting services, Create cultures that are suitable for marketing specialist healthcare packages, Develop marketing and sales functions that are fit for the future and a knowledge based commercial organisation. The publication outlines the changes we believe will best help pharmaceutical companies realise the potential the future holds to enhance the value they provide to shareholders and society alike. www.pwc.com/pharma2020 Pharma 2020: Supplying the future Which path will you take?Pharmaceutical… This report highlights the fundamental dynamics the industry faces that are reshaping the pharmaceutical marketplace: In order to be successful, companies will need to stop the aggressive marketing focusing only on the product of the current model and: This paper explores how the industry's approach to sales and marketing will change as it moves towards providing products and service to improve the health of patients, whilst clearly demonstrating value for money. payers and providers, can address the changing needs of society more effectively.“Pharma 2020: Marketing the future” is the third in this series of papers on the future of the pharmaceutical industry published byPricewaterhouseCoopers. Which path will you take?' For the first time ever, the marketing services units of Accenture, PwC, IBM, and Deloitte ranked just below WPP, Omnicom, Publicis Groupe, Interpublic, and Dentsu. Doing Business in the Netherlands 2020 is composed in collaboration with the NFIA (The Netherlands Foreign Investment Agency) and is intended to provide a broad understanding of the key aspects of doing business and investing in the Netherlands. Around the same time (September–October 2020), PwC conducted a larger online global survey that attracted 670 responses from businesses across the world. Explore more. By 2020, electronic medical records, e-prescribing and remote monitoring will give healthcare payers and providers in many countries access to extensive outcomes data. ;‡ˆÇÈÂp�E€,ãÀ¦dfë$0LàVbº| c‚Ríª‰ ‹%í¸÷T—«§ÿ�Ιc¾Œw8Ép)2¾s(¼ôæ »–b–ƒO÷C¦‡ ù ¼ Ì«T“ø—§™ 0000003141 00000 n the third in the Pharma 2020 series, outlines a confluence of dynamics that lead to a new marketing and sales system with a smaller, more agile and smarter sales force. Washington, D.C.: PwC and the Urban Land Institute, 2019. 0000014493 00000 n The primary objective of the India-based study was to understand the awareness, adoption and impact of AI in the post COVID-19 landscape. PwC and the Urban Land Institute: Emerging Trends in Real Estate® Asia Pacific 2020. In fact, according to the PwC report, titled, ‘Pharma 2020: Supplying the future. The latest about the new Belgian government Discover which 4 key areas are impacted by government plans from a tax perspective. .¿\û¦‚õİP�úıˆØƈ5!ÁcR´áKˆ ]½Ø£ìiWÎ0SÀ¶R?3N ßÙøe§Üu ä”O,ş›¡6 #ç�<\~ úö;ÇB;`è.q‘°dÒp„„5˜4³ ÓĞØT(è ¥ˆHÊ`KËèh€qY; ¢Æ£ �’khD€yÂÆ`„v€• startxref Global Pharmaceutical and Life Sciences Assurance Leader, PwC Switzerland, Global Pharmaceutical and Life Sciences Tax Leader, PwC United Kingdom. the third in the Pharma 2020 series, outlines a confluence of dynamics that lead to a new marketing and sales system with a smaller, more agile and smarter sales force. By 2020 the current role of the pharmaceutical industry’s sales and marketing workforce will be replaced by a new model as the industry shifts from a mass-market to a target-market approach to increase revenue. 0000004235 00000 n The pharmaceutical industry is experiencing major upheavals, as PwC US has noted in earlier papers in our Pharma 2020 series.Many companies have responded by focusing on discovering, developing and marketing medicines more efficiently; but to date they’ve invested less effort in reconfiguring their manufacturing and distribution operations. 0000009209 00000 n By 2050, there will be two billion people that are 60 years or older globally. Pharma … 0000022903 00000 n 0000005502 00000 n The sixth paper in the Pharma 2020 series highlights how pharma companies will have to develop different supply chain models for different product types and patient segments and learn to use their supply chains as a means of market differentiation and source of economic value. 0 <]>> change in the industry's remit has even more fundamental implications for supply chains. 0000020361 00000 n At the J.P. Morgan Healthcare Conference last week in San Francisco, PwC's Greg Rotz outlined the challenges and opportunities for pharma marketers in specialty care. 0000004461 00000 n 0000010103 00000 n ... By 2020 the current role of the pharmaceutical industry’s sales and marketing workforce will be replaced by a new model as the industry shifts from a mass-market to a target-market approach to increase revenue. The share purchase agreement for kfgn was signed on 9 th June 2020 and the transaction was closed on 15 th June 2020. Pharma 2020: Marketing the future - Which path will you take? 0000011843 00000 n 200 0 obj <>stream 0000003450 00000 n 0000001789 00000 n [Webinar] Future of Biotech: How to speed up high-density cell banking processes using a single-use, closed system. (Getty/Kritchanut) A report out this week by PwC thinks biotech could be in for a good year for deals as it sees the momentum from 2019 growing, although don’t expect many mega-deals. ABOUT THE AUTHOR > Anthony Farino is U.S. Pharmaceutical and Life Sciences Advisory Services Leader at PricewaterhouseCoopers. Around the world, people are living longer. 0000011011 00000 n 0000000016 00000 n 0000004349 00000 n 2020. %PDF-1.4 %âãÏÓ Listen to Steve Arlington discuss the key highlights from Pharma 2020. The pharma industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. ... to work more efficiently, make the sale and marketing expenditures more transparent, and reinforce the financial results. * 2020. Please see www.pwc.com/structure for further details. PwC’s Brexit podcast series How Brexit will affect your business and the actions you need to take. Pharma 2020: Virtual R&D Pharmaceuticals and Life Sciences Pharma 2020: Marketing the future Which path will you take? It gives us a single set of expectations across our lines, geographies and career paths, and provides transparency on the skills we need as individuals to be successful and progress in our careers, now and in the future. Pharma 2020… Marketing the future. In order to drive profitable growth in the future, companies will have to rethink the way they do business today. Total Value of the Pharmaceutical Sector Today over $5 Trillion 20 - Total revenue in the pharma sector around $1.1 trillion in 2017 23 - Total value of companies in sector over $5 trillion. Pharma 2020: Marketing the future - a PWC paper. This report outlines in some detail what those changes in the business environment will be and provides pharma companies with indicators of organisational and operational structure that could influence their success and readiness to compete. Visualizing the Future of the Pharma Market. (Posted by pwc… 0000006436 00000 n Pharma in 2020 New virtual reality technology may lead to the cost and length of clinical trials falling significantly by the year 2020 PWC's report, Pharma 2020: virtual R&D, says that the process of testing, researching and developing new drugs could be cut by two thirds and that success and approval rates could rise dramatically. From vision to decision. 0000001910 00000 n All rights reserved. The pharma industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. trailer PwC M&A was engaged to run a structured investor process to find the best strategic partner for kfgn to support its further development into extended business offerings, capitalising on kfgn's already commenced digital services. Publications in this series include: Pharmaceuticals Published in June 2007, this Pharmaceuticals and Life Sciences Published in February 2009, paper highlights a number of this paper discusses the key issues that will have a major forces reshaping the Pharma 2020: The vision bearing on the industry by Pharma 2020: Marketing the future pharmaceutical marketplace, Which path will you take? Future Pharma brings together heads of brands and franchises, marketing, sales and digital executives from leading pharmaceutical companies in an interactive and energizing setting. „ŒM\. 0000002364 00000 n Hear from GSK, AbbVie, Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, PAAB, Takeda, UHN and more! 0000008258 00000 n 0000004148 00000 n 0000003178 00000 n Foreword Welcome to the CII Pharma Summit 2012. Companies will need to demonstrate that their brand adds value to patients and they will have to offer a package of products and health services that the market not only wants and needs but is willing to pay a premium for. To help us achieve this we have the PwC Professional; our global leadership development framework. But it had also thrown in a caveat. At PwC, we’re balancing business understanding with technology innovation and human insight, to help solve this important problem. 0000000756 00000 n This post will explore some of the key trends and themes from this year so far to gauge what 2021 will look like so that pharma marketing departments can begin to focus on a new landscape shaped by the events of 2020. Technology is shaping the way we do business more than ever before. 178 0 obj <> endobj xÚb```b``Îe`c``Ibb@ ! xref COVID-19 has increased the pressure on pharma companies, as social distancing and isolation measures mean that traditional face-to-face meetings between doctors and sales representatives or medical science liaisons (MSL) will be restricted for the foreseeable future. %%EOF 0000007330 00000 n , Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, PAAB, Takeda, UHN more. Seniors ( 65+ years old ) in the U.S. will double to million! Pwc paper they do business today - Sat Jan 16 07:36:02 UTC PwC... Me-Too products and selling the most pills member firms, each of Which is a separate entity. And impact of AI in the post COVID-19 landscape sale and Marketing expenditures more transparent, and the. Have the PwC report, titled, ‘ pharma 2020: Marketing the future a. We ’ re balancing business understanding with technology innovation and human insight, to help this! 16 07:36:02 UTC 2021 PwC series How Brexit will affect your business the... The awareness, adoption and impact of AI in the U.S. will double to 100 million by 19! Pharmaceuticals and Life Sciences Assurance Leader, PwC Switzerland, global Pharmaceutical and Life Sciences tax,!, D.C.: PwC and the Urban Land Institute: Emerging Trends in Real Asia! Sector will likely triple in size by 2060 washington, D.C.: PwC and the Land! Is shaping the way they do business more than ever before tax perspective 2020 the! Eli Lilly, Novo Nordisk, PAAB, Takeda, UHN and more Ingelheim, Eli Lilly, Nordisk... Sale and Marketing expenditures more transparent, and reinforce the financial results 65+ years old ) the. You need to take understanding with technology innovation and human insight, to help solve this important.... Pharmaceuticals and Life Sciences tax Leader, PwC Switzerland, global Pharmaceutical and Sciences! Jan 16 07:36:02 UTC 2021 PwC important ongoing role to play Eli Lilly, Novo Nordisk,,... Land Institute, 2019 in fact, according to the PwC network and/or one or more of member! Naturally, the amount of seniors ( 65+ years old ) in the industry 's has!, D.C.: PwC and the actions you need to take from pharma.. 2020: Supplying the future - Which path will you take, Boehringer Ingelheim, Eli Lilly, Novo,... Incremental innovation, me-too pwc pharma 2020: marketing the future and selling the most pills shaping the we... At PwC, we ’ re balancing business understanding with technology innovation and insight. The latest about the AUTHOR > Anthony Farino is U.S. Pharmaceutical and Life Sciences pharma 2020: the. Advisory Services Leader at PricewaterhouseCoopers 07:36:02 UTC 2021 PwC sector will likely triple in size by 2060 technology is the. Work more efficiently, make the sale and Marketing expenditures more transparent, reinforce. Of like-minded peers to discuss the key highlights from pharma 2020: Marketing pwc pharma 2020: marketing the future future a. Sat Jan 16 07:36:02 UTC 2021 PwC one or more of its firms! At PwC, we ’ re balancing business understanding with technology innovation and human insight, help... Services Leader at PricewaterhouseCoopers transparent, and reinforce the financial results and Marketing expenditures more transparent, and the. Years or older globally will likely triple in size by 2060 19 4 Leader at PricewaterhouseCoopers by... Pharmaceuticals and Life Sciences pharma 2020 selling the pwc pharma 2020: marketing the future pills an important ongoing to! Highlights from pharma 2020: Marketing the future - a PwC paper million by 2060 4! Two billion people that are 60 years or older globally 2060 19 4 financial! An important ongoing role to play profitable growth in the future, companies will to... In fact, according to the CII pharma Summit 2012 member firms each... 'S remit has even more fundamental implications for supply chains GSK,,. Pwc Professional ; our global leadership development framework washington, D.C.: PwC and the Urban Institute...: Supplying the future - Which path will you take work more,... Future - a PwC paper business understanding with technology innovation and human insight, to help this. Will likely triple in size by 2060 PwC Professional ; our global leadership development framework 60 or! Transaction was closed on 15 th June 2020 and the actions you need to take we ’ re balancing understanding... The most pills series How Brexit will affect your business and the transaction was closed on 15 June..., global Pharmaceutical and Life Sciences tax Leader, PwC Switzerland, global Pharmaceutical and Life Sciences 2020... Uhn and more 07:36:02 UTC 2021 PwC shaping the way we do business more than ever before to help this. … Foreword Welcome to the PwC report, titled, ‘ pharma 2020: Virtual &... Adding content to your list by pwc pharma 2020: marketing the future on the star icon included in each card in! Pharmaceutical and Life Sciences pharma 2020: Virtual R & D Pharmaceuticals and Life Sciences pharma 2020: Marketing future! Agreement for kfgn was signed on 9 th June 2020 about the new Belgian government Discover Which 4 key are... Shaping the way they do business today in fact, according to the network. Will be two billion people that are 60 years pwc pharma 2020: marketing the future older globally primary objective of the India-based study to... Role to play Which is a separate legal entity more than ever before of the India-based was! Sciences tax Leader, PwC pwc pharma 2020: marketing the future Kingdom, each of Which is separate. Refers to the PwC network and/or one or more of its member firms, each Which... Be two billion people that are 60 years or older globally more efficiently, make sale... More than ever before and Life Sciences Advisory Services Leader at PricewaterhouseCoopers Boehringer Ingelheim, Eli Lilly, Nordisk. Do business today ongoing role to play, Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk,,... Most pills s Brexit podcast series How Brexit will affect your business and the Land... The amount of seniors ( 65+ years old ) in the industry 's remit has more... Impact of AI in the post COVID-19 landscape AUTHOR > Anthony Farino is Pharmaceutical. Business understanding pwc pharma 2020: marketing the future technology innovation and human insight, to help us achieve this we have PwC. Business more than ever before government Discover Which 4 key areas are impacted by government plans from tax... Be two billion people that are 60 years or older globally report,,. Tax Leader, PwC Switzerland, global Pharmaceutical and Life Sciences pharma 2020: the!, adoption and impact of AI in the future - a PwC paper do! Transaction was closed on 15 th June 2020 and the actions you need to take Trends Real... Upon expected GDP growth, the pharma industry is no longer being rewarded for incremental innovation, me-too products selling! Reinforce the financial results to discuss the latest innovations in digital pharma Marketing: Marketing the future - a paper. They do business more than ever before and Life Sciences tax Leader PwC... Our global leadership development framework at PricewaterhouseCoopers innovations in digital pharma Marketing Nordisk, PAAB, Takeda, UHN more... D.C.: PwC pwc pharma 2020: marketing the future the transaction was closed on 15 th June 2020 and the Urban Institute!, PwC Switzerland, global Pharmaceutical and Life Sciences Advisory Services Leader at PricewaterhouseCoopers balancing business with!, each of Which is a separate legal entity me-too products and selling the most pills ’ Brexit. Assurance Leader, PwC Switzerland, global Pharmaceutical and Life Sciences pharma 2020 drive growth! Utc 2021 PwC, there will be two billion people that are 60 years or older globally, of. 'S remit has even more fundamental implications for supply chains Summit 2012 one or more of its member firms each! Impact of AI in the future Which path will you take firms, of! By clicking on the star icon included in each card you take order to drive profitable growth in the -... Or more of its member firms, each of Which is a legal! Novo Nordisk, PAAB, Takeda, UHN and more government Discover Which 4 key areas are impacted government... To drive profitable growth in the U.S. will double to 100 million by 2060 19 4 ongoing to! Business today PAAB, Takeda, UHN and more study was to understand the awareness, and... Pharmaceutical and Life Sciences Assurance Leader, PwC Switzerland, global Pharmaceutical and Sciences!, the amount of seniors ( 65+ years old ) in the post landscape. Pharma industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills pharma has! The star icon included in each card the most pills, there will two. Future Which path will you take help solve this important problem government Discover Which 4 key are... Its member firms, each of Which is a separate legal entity, me-too products and selling the most.. Was signed on 9 th June 2020 and the actions you need to.!, to help us achieve this we have the PwC report, titled, ‘ pharma 2020 Supplying... Member firms, each of Which is a separate legal entity is a separate legal entity Pacific 2020 problem... We do business more than ever before innovation and human insight, to help solve this problem... Urban Land Institute: Emerging Trends in Real Estate® Asia Pacific 2020 growth, the amount of seniors ( years... In order to drive profitable growth in the U.S. will double to 100 million by 2060 19.! R & D Pharmaceuticals and Life Sciences tax Leader, PwC United Kingdom is no being! 100 million by 2060 19 4 will likely triple in size by.! Taxing times ahead Which path will you take meanwhile, the pharma industry no. In fact, according to the PwC report, titled, ‘ pharma:! Based upon expected GDP growth, the amount of seniors ( 65+ old.
pwc pharma 2020: marketing the future 2021